skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 65  for All Library Resources

Results 1 2 3 4 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Material Type:
Article
Add to My Research

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

The New England journal of medicine, 2020-10, Vol.383 (15), p.1413-1424 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2022190 ;PMID: 32865377

Full text available

2
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status: Results From the EMPEROR-Reduced Trial
Material Type:
Article
Add to My Research

Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status: Results From the EMPEROR-Reduced Trial

Circulation (New York, N.Y.), 2021-01, Vol.143 (4), p.337-349 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;2020 The Authors. 2020 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.120.051824 ;PMID: 33175585

Full text available

3
Characteristics and outcomes of patients screened for transcatheter mitral valve implantation: 1-year results from the CHOICE-MI registry
Material Type:
Article
Add to My Research

Characteristics and outcomes of patients screened for transcatheter mitral valve implantation: 1-year results from the CHOICE-MI registry

European journal of heart failure, 2022-05, Vol.24 (5), p.887-898 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.2492 ;PMID: 35338542

Digital Resources/Online E-Resources

4
Early changes in estimated glomerular filtration rate post‐initiation of empagliflozin in EMPEROR‐Reduced
Material Type:
Article
Add to My Research

Early changes in estimated glomerular filtration rate post‐initiation of empagliflozin in EMPEROR‐Reduced

European journal of heart failure, 2022-10, Vol.24 (10), p.1829-1839 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.2578 ;PMID: 35711093

Digital Resources/Online E-Resources

5
Adaptive servo ventilation for sleep apnoea in heart failure: the FACE study 3-month data
Material Type:
Article
Add to My Research

Adaptive servo ventilation for sleep apnoea in heart failure: the FACE study 3-month data

Thorax, 2022-02, Vol.77 (2), p.178-185 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 ;ISSN: 0040-6376 ;EISSN: 1468-3296 ;DOI: 10.1136/thoraxjnl-2021-217205 ;PMID: 34230094

Full text available

6
Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR‐Reduced
Material Type:
Article
Add to My Research

Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR‐Reduced

European journal of heart failure, 2022-12, Vol.24 (12), p.2297-2304 [Peer Reviewed Journal]

Attribution ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.2707 ;PMID: 36194680

Digital Resources/Online E-Resources

7
Patiromer for the management of hyperkalaemia in patients receiving renin‐angiotensin‐aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial
Material Type:
Article
Add to My Research

Patiromer for the management of hyperkalaemia in patients receiving renin‐angiotensin‐aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial

European journal of heart failure, 2022-01, Vol.24 (1), p.230 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1388-9842 ;ISSN: 1879-0844 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.2386 ;PMID: 34800079

Digital Resources/Online E-Resources

8
Presence of Peripheral Artery Disease Is Associated With Increased Risk of Heart Failure Events: Insights From EMPEROR-Pooled
Material Type:
Article
Add to My Research

Presence of Peripheral Artery Disease Is Associated With Increased Risk of Heart Failure Events: Insights From EMPEROR-Pooled

Arteriosclerosis, thrombosis, and vascular biology, 2023-07, Vol.43 (7), p.1334-1337 [Peer Reviewed Journal]

Attribution ;2023 The Authors. 2023 ;ISSN: 1079-5642 ;EISSN: 1524-4636 ;DOI: 10.1161/ATVBAHA.123.319156 ;PMID: 37199158

Full text available

9
SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA
Material Type:
Article
Add to My Research

SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA

Nephrology, dialysis, transplantation, 2023-10, Vol.38 (11), p.2444-2455 [Peer Reviewed Journal]

The Author(s) 2023. Published by Oxford University Press on behalf of the ERA. 2023 ;Attribution - NonCommercial ;ISSN: 0931-0509 ;EISSN: 1460-2385 ;DOI: 10.1093/ndt/gfad112 ;PMID: 37230946

Digital Resources/Online E-Resources

10
Comparison of interleukin-6 and high-sensitivity C-reactive protein for cardiovascular risk assessment: Findings from the MESA study
Material Type:
Article
Add to My Research

Comparison of interleukin-6 and high-sensitivity C-reactive protein for cardiovascular risk assessment: Findings from the MESA study

Atherosclerosis, 2024-03, Vol.390 [Peer Reviewed Journal]

Attribution - NonCommercial - NoDerivatives ;ISSN: 0021-9150 ;EISSN: 1879-1484 ;DOI: 10.1016/j.atherosclerosis.2024.117461 ;PMID: 38306764

Digital Resources/Online E-Resources

11
Letter regarding the article ‘Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial
Material Type:
Article
Add to My Research

Letter regarding the article ‘Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial

European journal of heart failure, 2022-11, Vol.24 (11) [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.2694 ;PMID: 36114733

Digital Resources/Online E-Resources

12
The prevalence and clinical associations of ultrasound measures of congestion in patients at risk of developing heart failure
Material Type:
Article
Add to My Research

The prevalence and clinical associations of ultrasound measures of congestion in patients at risk of developing heart failure

European journal of heart failure, 2021-11, Vol.23 (11), p.1831-1840 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.2353 ;PMID: 34632680

Digital Resources/Online E-Resources

13
Outcome of Temporary Circulatory Support As a Bridge-to-Left Ventricular Assist Device Strategy in Cardiogenic Shock Patients
Material Type:
Article
Add to My Research

Outcome of Temporary Circulatory Support As a Bridge-to-Left Ventricular Assist Device Strategy in Cardiogenic Shock Patients

Critical care medicine, 2022-05, Vol.50 (5), p.e426-e433 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0090-3493 ;EISSN: 1530-0293 ;DOI: 10.1097/CCM.0000000000005424 ;PMID: 34974497

Digital Resources/Online E-Resources

14
Albiglutide in patients with type 2 diabetes and heart failure: a post‐hoc analysis from Harmony Outcomes
Material Type:
Article
Add to My Research

Albiglutide in patients with type 2 diabetes and heart failure: a post‐hoc analysis from Harmony Outcomes

European journal of heart failure, 2022-10, Vol.24 (10), p.1792-1801 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.2660 ;PMID: 36053803

Digital Resources/Online E-Resources

15
Characteristics, management, and mid-term prognosis of older adults with cardiogenic shock admitted to intensive care units: Insights from the FRENSHOCK registry
Material Type:
Article
Add to My Research

Characteristics, management, and mid-term prognosis of older adults with cardiogenic shock admitted to intensive care units: Insights from the FRENSHOCK registry

International journal of cardiology, 2024-01 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0167-5273 ;EISSN: 1874-1754 ;DOI: 10.1016/j.ijcard.2023.131578 ;PMID: 37956759

Digital Resources/Online E-Resources

16
Glucagon‐like peptide 1 receptor agonists in patients with type 2 diabetes with and without chronic heart failure: a meta‐analysis of randomized placebo‐controlled outcome trials
Material Type:
Article
Add to My Research

Glucagon‐like peptide 1 receptor agonists in patients with type 2 diabetes with and without chronic heart failure: a meta‐analysis of randomized placebo‐controlled outcome trials

Diabetes, obesity & metabolism, 2023-06, Vol.25 (6), p.1495-1502

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1462-8902 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.14997 ;PMID: 36722252

Digital Resources/Online E-Resources

17
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): results in the pre-specified subgroup with heart failure
Material Type:
Article
Add to My Research

Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): results in the pre-specified subgroup with heart failure

European journal of heart failure, 2020-08, Vol.22 (8), p.1462-1471 [Peer Reviewed Journal]

Attribution - NonCommercial ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.1860 ;PMID: 32452085

Digital Resources/Online E-Resources

18
Comparing and contrasting risk factors for Heart failure in patients with and without history of myocardial infarction: Data from HOMAGE and the UK Biobank
Material Type:
Article
Add to My Research

Comparing and contrasting risk factors for Heart failure in patients with and without history of myocardial infarction: Data from HOMAGE and the UK Biobank

European journal of heart failure, 2022-06 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.2495 ;PMID: 35365899

Digital Resources/Online E-Resources

19
Efficacy and safety profile of SGLT2 inhibitors in the elderly: How is the benefit/risk balance?
Material Type:
Article
Add to My Research

Efficacy and safety profile of SGLT2 inhibitors in the elderly: How is the benefit/risk balance?

Diabetes & metabolism, 2023-03, Vol.49 (2), p.101419-101419, Article 101419 [Peer Reviewed Journal]

2023 ;Copyright © 2023. Published by Elsevier Masson SAS. ;Attribution - NonCommercial ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2023.101419 ;PMID: 36640828

Full text available

20
Characteristics, management, and outcomes of patients with left‐sided infective endocarditis complicated by heart failure: a substudy of the ESC‐EORP EURO‐ENDO (European infective endocarditis) registry
Material Type:
Article
Add to My Research

Characteristics, management, and outcomes of patients with left‐sided infective endocarditis complicated by heart failure: a substudy of the ESC‐EORP EURO‐ENDO (European infective endocarditis) registry

European journal of heart failure, 2022-07, Vol.24 (7), p.1253-1265 [Peer Reviewed Journal]

Attribution - NonCommercial - NoDerivatives ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.2525

Digital Resources/Online E-Resources

Results 1 - 20 of 65  for All Library Resources

Results 1 2 3 4 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (63)

Refine My Results

Creation Date 

From To
  1. Before 2008  (2)
  2. 2008 To 2014  (5)
  3. 2015 To 2016  (3)
  4. 2017 To 2019  (11)
  5. After 2019  (45)
  6. More options open sub menu

Language 

  1. Japanese  (4)
  2. Norwegian  (2)
  3. More options open sub menu

Searching Remote Databases, Please Wait